Basic Materials / Specialty ChemicalsJakartaID
$158.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $75.1B · quality 74.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
36/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$552.0B
P/E
N/A
•EV/EBITDA
N/A
•ROE
4.3%
↑Gross Margin
27.8%
↑Debt/Equity
0.02
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2000–2025 · 25 años de histórico normalizado
Revenue CAGR
+7.7%
FCF CAGR
+11.8%
FCF margin
17.3%
FCF / Net income
1.73x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $529.53B · net income $53.02B · FCF $91.78B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||||||||||
| Revenue | $529.53B | $529.53B | $530.43B | $518.36B | $614.48B | $629.88B | $671.54B | $758.30B | $739.58B | $643.59B | $568.64B | $531.54B | $526.57B | $418.67B | $385.04B | $328.46B | $254.28B | $205.22B | $182.65B | $146.91B | $110.13B | $104.74B | $79.60B | $81.87B | $76.51B | $80.34B | $82.04B |
| Net Income | $53.02B | $53.02B | $64.44B | $71.94B | $76.72B | $104.41B | $93.50B | $73.77B | $72.36B | $75.36B | $87.81B | $47.15B | $40.27B | $38.85B | $35.97B | $26.38B | $24.49B | $16.44B | $4.61B | $4.23B | $5.76B | $5.18B | $4.47B | $4.34B | $6.25B | $5.98B | $6.09B |
| EBITDA | $75.10B | $75.10B | $103.59B | $83.98B | $120.11B | $153.39B | $150.99B | $131.77B | $127.17B | $124.04B | $136.16B | $86.73B | $75.79B | $69.23B | $59.57B | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS | 15.18 | 15.18 | 18.44 | 20.59 | 21.96 | 29.88 | 26.76 | 21.11 | 20.71 | 21.57 | 25.13 | 13.49 | 11.46 | 11.12 | 10.30 | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross Margin | 27.8% | 27.8% | 29.8% | 33.2% | 29.7% | 34.1% | 32.0% | 27.9% | 26.2% | 29.2% | 34.1% | 27.9% | 25.3% | 27.7% | 26.0% | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 9.8% | 9.8% | 12.0% | 15.0% | 14.5% | 20.9% | 18.5% | 14.3% | 13.3% | 16.3% | 21.2% | 14.5% | 12.3% | 14.4% | 13.5% | 12.6% | 14.6% | 12.6% | 5.0% | 3.6% | 3.6% | 3.2% | 7.4% | 5.1% | 5.7% | 6.3% | 9.2% |
| Net Margin | 10.0% | 10.0% | 12.1% | 13.9% | 12.5% | 16.6% | 13.9% | 9.7% | 9.8% | 11.7% | 15.4% | 8.9% | 7.6% | 9.3% | 9.3% | 8.0% | 9.6% | 8.0% | 2.5% | 2.9% | 5.2% | 5.0% | 5.6% | 5.3% | 8.2% | 7.4% | 7.4% |
| Balance Sheet | |||||||||||||||||||||||||||
| Debt/Equity | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.05 | 0.04 | 0.03 | 0.05 | 0.06 | 0.06 | 0.12 | 0.32 | 0.29 | 0.01 | 0.03 | 0.06 | 0.12 | 0.19 | — | — | — | — | — | — | — | — |
| Current Ratio | 14.07 | 14.07 | 15.03 | 14.21 | 11.76 | 7.76 | 8.11 | 6.92 | 5.05 | 4.52 | 4.89 | 3.57 | 2.33 | 2.33 | 2.41 | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | |||||||||||||||||||||||||||
| Free Cash Flow | $91.78B | $91.78B | $37.51B | $75.15B | $86.96B | $31.28B | $220.62B | $85.49B | $20.97B | $19.80B | $42.73B | $90.46B | $-8.00B | $-6.34B | $9.70B | $9.07B | $866.2M | — | — | $1.38B | — | $6.94B | — | $2.08B | $4.24B | $10.80B | $5.66B |
| Returns | |||||||||||||||||||||||||||
| ROE | 4.3% | 4.3% | 5.6% | 6.5% | 7.1% | 10.5% | 10.1% | 8.9% | 10.3% | 11.8% | 15.4% | 17.3% | 16.2% | 17.7% | 20.7% | 20.3% | 23.0% | 23.7% | 7.8% | 7.0% | 10.0% | 9.5% | 8.4% | 8.7% | 12.9% | 12.8% | 13.9% |
| Growth & Yield | |||||||||||||||||||||||||||
| Revenue Growth | -0.2% | -0.2% | 2.3% | -15.6% | -2.4% | -6.2% | -11.4% | 2.5% | 14.9% | 13.2% | 7.0% | 0.9% | 25.8% | 8.7% | 17.2% | 29.2% | 23.9% | 12.4% | 24.3% | 33.4% | 5.1% | 31.6% | -2.8% | 7.0% | -4.8% | -2.1% | — |
| EPS Growth | -17.7% | -17.7% | -10.4% | -6.2% | -26.5% | 11.7% | 26.8% | 1.9% | -4.0% | -14.2% | 86.3% | 17.7% | 3.1% | 8.0% | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-2.6%
EPS terminal req.
$14.02
Spread vs growth
-15.1%
5Y implied EPS CAGR
2.3%
EPS terminal req.
$16.96
Spread vs growth
-20.0%
10Y implied EPS CAGR
6.1%
EPS terminal req.
$27.32
Spread vs growth
-23.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-18.6%
Start / end P/E
10.5x → 10.4x
EPS bridge
18.44 → 15.18
Residual
+0.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.